Identification of regulatory variants of carboxylesterase 1 (CES1): A proof‐of‐concept study for the application of the Allele‐Specific Protein Expression (ASPE) assay in identifying cis‐acting regulatory genetic polymorphisms

It is challenging to study regulatory genetic variants as gene expression is affected by both genetic polymorphisms and non‐genetic regulators. The mRNA allele‐specific expression (ASE) assay has been increasingly used for the study of cis‐acting regulatory variants because cis‐acting variants affect gene expression in an allele‐specific manner. However, poor correlations between mRNA and protein expressions were observed for many genes, highlighting the importance of studying gene expression regulation at the protein level. In the present study, we conducted a proof‐of‐concept study to utilize a recently developed allele‐specific protein expression (ASPE) assay to identify the cis‐acting regulatory variants of CES1 using a large set of human liver samples. The CES1 gene encodes for carboxylesterase 1 (CES1), the most abundant hepatic hydrolase in humans. Two cis‐acting regulatory variants were found to be significantly associated with CES1 ASPE, CES1 protein expression, and its catalytic activity on enalapril hydrolysis in human livers. Compared to conventional gene expression‐based approaches, ASPE demonstrated an improved statistical power to detect regulatory variants with small effect sizes since allelic protein expression ratios are less prone to the influence of non‐genetic regulators (e.g., diseases and inducers). This study suggests that the ASPE approach is a powerful tool for identifying cis‐regulatory variants.

[1]  C. Myers,et al.  Trans-acting genetic variation affects the expression of adjacent genes , 2020, bioRxiv.

[2]  Hui Jiang,et al.  Genome-wide pQTL analysis of protein expression regulatory networks in the human liver , 2020, BMC Biology.

[3]  A. Rostami-Hodjegan,et al.  Characterization of CYP2B6 K262R allelic variants by quantitative allele-specific proteomics using a QconCAT standard. , 2020, Journal of pharmaceutical and biomedical analysis.

[4]  Lucy Her,et al.  Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators , 2019, Drug Metabolism and Disposition.

[5]  Xinwen Wang,et al.  Comparative Proteomics Analysis of Human Liver Microsomes and S9 Fractions , 2019, Drug Metabolism and Disposition.

[6]  Andy B. Chen,et al.  Allele-specific expression and high-throughput reporter assay reveal functional genetic variants associated with alcohol use disorders , 2019, Molecular Psychiatry.

[7]  Hui Jiang,et al.  Label-free absolute protein quantification with data-independent acquisition. , 2019, Journal of proteomics.

[8]  Qinghua Zhang,et al.  Patterns of genome-wide allele-specific expression in hybrid rice and the implications on the genetic basis of heterosis , 2019, Proceedings of the National Academy of Sciences.

[9]  Yixue Li,et al.  A Genome-Wide Study of Allele-Specific Expression in Colorectal Cancer , 2018, Front. Genet..

[10]  A. Nesvizhskii,et al.  Determining Allele-Specific Protein Expression (ASPE) Using a Novel Quantitative Concatamer Based Proteomics Method. , 2018, Journal of proteome research.

[11]  Hui Jiang,et al.  Comparison of protein expression between human livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes. , 2018, Drug metabolism and pharmacokinetics.

[12]  Guangbo Ge,et al.  Human carboxylesterases: a comprehensive review , 2018, Acta pharmaceutica Sinica. B.

[13]  Xinwen Wang,et al.  A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms , 2017, Drug Metabolism and Disposition.

[14]  Tim F. Rayner,et al.  Interplay of cis and trans mechanisms driving transcription factor binding and gene expression evolution , 2016, Nature Communications.

[15]  Wei Zhang,et al.  Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients , 2017, Scientific Reports.

[16]  Joo-Youn Cho,et al.  The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans , 2017, PloS one.

[17]  W. Sadee,et al.  Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus , 2016, Pharmacogenetics and genomics.

[18]  G. Wang,et al.  CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors , 2015, The Pharmacogenomics Journal.

[19]  Marko Pfeifer,et al.  An Introduction To Genetic Analysis , 2016 .

[20]  V. Anne Smith,et al.  Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system , 2015 .

[21]  D. Finkelstein,et al.  The CYP 2 C 19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP 2 C 19 * 35 and CYP 2 C 19 * 2 Alleles s , 2015 .

[22]  Bin Jiang,et al.  The effects of CES1A2 A(−816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease , 2014, Pharmacogenetics and genomics.

[23]  D. Hartl,et al.  The roles of cis- and trans-regulation in the evolution of regulatory incompatibilities and sexually dimorphic gene expression , 2014, Genome research.

[24]  Katherine A. Johnson,et al.  Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit/hyperactivity disorder-associated CES1 gene. , 2013, Journal of child and adolescent psychopharmacology.

[25]  A. Rostami-Hodjegan,et al.  Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transporters. , 2013, Journal of proteome research.

[26]  W. Bickmore,et al.  Regulation from a distance: long-range control of gene expression in development and disease , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[27]  V. Herring,et al.  The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance? , 2013, Pharmacotherapy.

[28]  J. O’Connell,et al.  The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response , 2013, Pharmacogenetics and genomics.

[29]  Tetsuya Terasaki,et al.  Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities , 2012, Drug Metabolism and Disposition.

[30]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[31]  E. Dermitzakis,et al.  From expression QTLs to personalized transcriptomics , 2011, Nature Reviews Genetics.

[32]  Teruhiko Yoshida,et al.  Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients. , 2010, British journal of clinical pharmacology.

[33]  A. Brooks-Wilson,et al.  Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity , 2010, The Pharmacogenomics Journal.

[34]  Julie A. Johnson,et al.  Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. , 2008, American journal of human genetics.

[35]  Tomomi Kimura,et al.  Functional polymorphisms in carboxylesterase1A2 (CES1A2) gene involves specific protein 1 (Sp1) binding sites. , 2008, Biochemical and biophysical research communications.

[36]  Kaoru Kobayashi,et al.  Structural organization and characterization of the regulatory element of the human carboxylesterase (CES1A1 and CES1A2) genes. , 2008, Drug metabolism and pharmacokinetics.

[37]  K. Tanimoto,et al.  Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT-11 cytotoxicity in vitro , 2007, Pharmacogenetics & Genomics.

[38]  Teruko Imai,et al.  Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine , 2006, Drug Metabolism and Disposition.

[39]  Tomomi Kimura,et al.  A Single Nucleotide Polymorphism in the Carboxylesterase Gene Is Associated with the Responsiveness to Imidapril Medication and the Promoter Activity , 2005, Hypertension Research.

[40]  R. Lewontin,et al.  Transcription: an overview of gene regulation in eukaryotes , 2000 .

[41]  R. D. Dyson,et al.  Essentials of cell biology , 1975 .